Cargando…
Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism
BACKGROUND: Cholesteatoma disease is an expanding lesion in the middle ear. Hearing loss and facial paralysis alongside with other intracranial complications are found. No pharmaceutical treatment is available today and recurrence after surgical extraction occurs. We investigated possible TLR4-based...
Autores principales: | Schürmann, Matthias, Oppel, Felix, Shao, Senyao, Volland-Thurn, Verena, Kaltschmidt, Christian, Kaltschmidt, Barbara, Scholtz, Lars-Uwe, Sudhoff, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903614/ https://www.ncbi.nlm.nih.gov/pubmed/33627146 http://dx.doi.org/10.1186/s12964-020-00690-y |
Ejemplares similares
-
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS
por: Schürmann, Matthias, et al.
Publicado: (2020) -
Stem cells in middle ear cholesteatoma contribute to its pathogenesis
por: Nagel, Julia, et al.
Publicado: (2018) -
Review of potential medical treatments for middle ear cholesteatoma
por: Schürmann, Matthias, et al.
Publicado: (2022) -
Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy
por: Goon, Peter, et al.
Publicado: (2023) -
Translabyrinthine Petrous Apex Cholesteatoma Surgery with Hearing Preservation
por: Sudhoff, Holger, et al.
Publicado: (2021)